Chris Murphy actually said...
This increased cost is born by our healthcare system as a whole, but more specifically by patients as more and more insurance companies place higher cost sharing burdens on biologics.
Context
Murphy discusses the financial burden of biologics on patients and the healthcare system.
09/16/2015